Gaffney, K., Weinberg, M., Soto, M., Louie, S., & Rodgers, K. (2018). Development of angiotensin II (1-7) analog as an oral therapeutic for the treatment of chemotherapy-induced myelosuppression. Haematologica.
Stile di citazione ChicagoGaffney, Kevin, Michael Weinberg, Maira Soto, Stan Louie, e Kathleen Rodgers. "Development of Angiotensin II (1-7) Analog As an Oral Therapeutic for the Treatment of Chemotherapy-induced Myelosuppression." Haematologica 2018.
Citazione MLAGaffney, Kevin, et al. "Development of Angiotensin II (1-7) Analog As an Oral Therapeutic for the Treatment of Chemotherapy-induced Myelosuppression." Haematologica 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.